Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Change in Receivables (2022 - 2025)

Historic Change in Receivables for Cardio Diagnostics Holdings (CDIOW) over the last 4 years, with Q3 2025 value amounting to -$1706.0.

  • Cardio Diagnostics Holdings' Change in Receivables fell 12592.71% to -$1706.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2879.0, marking a year-over-year decrease of 12093.82%. This contributed to the annual value of $13652.0 for FY2024, which is 17524.19% up from last year.
  • Per Cardio Diagnostics Holdings' latest filing, its Change in Receivables stood at -$1706.0 for Q3 2025, which was down 12592.71% from $3375.0 recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Change in Receivables registered a high of $14028.0 during Q1 2024, and its lowest value of -$11468.0 during Q2 2024.
  • For the 4-year period, Cardio Diagnostics Holdings' Change in Receivables averaged around $938.18, with its median value being $1050.0 (2023).
  • Examining YoY changes over the last 5 years, Cardio Diagnostics Holdings' Change in Receivables showed a top increase of 104000.0% in 2024 and a maximum decrease of 119219.05% in 2024.
  • Over the past 4 years, Cardio Diagnostics Holdings' Change in Receivables (Quarter) stood at -$901.0 in 2022, then soared by 611.65% to $4610.0 in 2023, then decreased by 2.13% to $4512.0 in 2024, then crashed by 137.81% to -$1706.0 in 2025.
  • Its Change in Receivables was -$1706.0 in Q3 2025, compared to $3375.0 in Q2 2025 and -$9060.0 in Q1 2025.